Uterine papillary serous carcinoma: Patterns of failure and survival

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 49, Issue 4, 2009, Pages 419-425

  Wang, Wei ^a   Do, Viet ^a   Hogg, Russell ^a   Wain, Gerard ^a   Brand, Alison ^a   Bull, Colin ^a   Stenlake, Annie ^a   Gebski, Val ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cytoreductive surgery; Pattern of failure; Pelvic radiotherapy; Survival; Uterine papillary serous carcinoma; Vaginal brachytherapy

Indexed keywords

CARBOPLATIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; AUSTRALIA; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SALPINGOOOPHORECTOMY; TREATMENT FAILURE; UTERINE PAPILLARY SEROUS CARCINOMA; UTERUS CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUSTRALIA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT FAILURE; UTERINE NEOPLASMS;

EID: 70350151689     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2009.01016.x     Document Type: Article

References (29)

1. Lauchlan SC. Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med 1981; 105: 615-618.
2. Hendrickson M, Ross J, Eifel PJ et al. Adenocarcinoma of the endometrium: Analysis of 256 cases with carcinoma limited to the uterine corpus. Pathological review and analysis of prognostic variables. Gynecol Oncol 1982; 13: 373-392.
3. Ioffe OB, Simsir A, Silverberg SG. Pathology. In: Berek JS, Hacker NF, eds. Practical Gynecologic Oncology. Philadelphia, PA: Lippincott Williams & Wilkins, 2000; 159-244.
4. Kelly MG, O'Malley DM, Hui P et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol 2005; 98: 353-359.
5. Huh WK, Powell M, Leath CA et al. Uterine papillary serous carcinoma: Comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gycecol Oncol 2003; 91: 470-475.
6. Alobaid A, Bruchim I, Verkooijen H et al. Adjuvant therapy for patients with stage I papillary serous endometrial cancer. Eur J Sur Oncol 2006; 32: 358-362.
7. Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 1st edn. Geneva: WHO Press, 2003; 224-226.
8. Bristow RE, Duska LR, Montz FJ. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma. Gynecol Oncol 2001; 81: 92-99.
9. Moller KA, Gehrig PA, Van Le L et al. The role of optimal debulking in advanced stage serous carcinoma of the uterus. Gynecol Oncol 2004; 94: 170-174.
10. Boruta DM, Gehrig PA, Groben PA et al. Uterine serous and grade 3 endometrioid carcinoma: Is there a survival differences? Cancer 2004; 101: 2214.
11. Goff BA, Kato D, Schmidt RA et al. Uterine papillary serous carcinoma: Pattern of metastatic spread. Gynecol Oncol 1994; 54: 264-268.
12. Lim P, Al Kushi A, Gilks B et al. Early stage uterine papillary serous carcinoma of the endometrium: Effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome. Cancer 2001; 91: 752-757.
13. Faratian D, Stillie A, Busby-Early RM et al. A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome. Int J Gynecol Cancer 2006; 16: 972-978.
14. Sood BM, Jones J, Gupta S et al. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys 2003; 57: 208-216.
15. Sutton G, Axelrod J, Bundy BN et al. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: A gynecologic oncology group study. Gynecol Oncol 2005; 97: 755-763.
16. Mallipeddi P, Kapp DS, Teng NH. Long-term survival with adjuvant whole abdominal irradiation for uterine papillary serous carcinoma. Cancer 1993; 71: 3076-3081.
17. Gibbons S, Martinez A, Schray M et al. Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma. Int J Radiat Oncol Biol Phys 1991; 21: 1019-1025.
18. Low JS, Wong EH, Khoo Tan HS et al. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma. Gynecol Oncol 2005; 97: 171-177.
19. Fleming GF. Systemic management of endometrial cancers with unusual histology. American Society of Clinical Oncology 2004 Education Book. 40th Annual Meeting. Alexandria: American Society of Clinical Oncology, 2004; pp. 293-297.
20. Kelly MG, O'Malley D, Hui P et al. Patients with uterine papillary serous cancers may benefit from adjuvant platinumbased chemoradiation. Gynecol Oncol 2004; 95: 469-473.
21. Keys HM, Roberts JA, Brunnetto VL et al. A phase III trial of surgery with or without adjuvant external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A gynecologic oncology group study. Gynecol Oncol 2004; 92: 744-751.
22. Creutzberg CL, van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicenter randomized trial. The Lancet 2000; 355: 1406-1411.
23. Martin JD, Gilks B, Lim P. Papillary serous carcinoma - A less radio-sensitive subtype of endometrial cancer. Gynecol Oncol 2005; 98: 299-303.
24. Smith RS, Kapp DS, Chen Q et al. Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy. Int J Radiat Oncol Biol Phys 2000; 48: 767-778.
25. Martinez AA, Weiner S, Podratz K et al. Improved outcome at 10 years for serous papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdominopelvic irradiation. Gynecol Oncol 2003; 90: 537-546.
26. Kwon J, Ackerman I, Franssen E. The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys 2004; 59: 1439-1445.
27. Randall ME, Filiaci VL, Muss H et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study. J Clin Oncol 2006; 24: 36-44.
28. Steed H, Manchul L, Rosen B et al. Uterine papillary serous carcinoma: Evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy. Int J Gynecol Cancer 2006; 16: 278-285.
29. Havrilesky LJ, Secord AA, Bae-Jump V et al. Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol 2007; 105: 677-682.